论文部分内容阅读
20年代初,中国中医研究院中药研究所在筛选抗肿瘤药物的研究过程中,发现中药猪苓的提取物—猪苓多糖具有抗癌、增强免疫功能和保肝作用,从而试用于治疗乙型肝炎.经过多年的实验研究和临床验证,说明对乙型肝炎具有明显疗效.近年,上海巫善明等采用猪苓多糖合并乙肝疫苗的治疗方法,更加提高了疗效,HBsAg 阴转率达60%,HBV DNA 阴转率67.5%,现将实验室及临床研究概况介绍如下.
In the early 1920s, Institute of Chinese Materia Medica, Chinese Academy of Traditional Chinese Medicine in the screening of anti-tumor drugs in the process of discovery, the Chinese medicine Polyporus umbellatus extract - Polyporus umbellatus polysaccharide with anti-cancer, enhance immune function and hepatoprotective effect, and thus for the treatment of type B Hepatitis.After many years of experimental research and clinical validation, indicating that significant effect on hepatitis B. In recent years, Shanghai Wuxian Ming and other treatment with Polyporus umbellatus polysaccharide combined with hepatitis B vaccine to further improve the efficacy of HBsAg negative conversion rate of 60% HBV DNA negative conversion rate of 67.5%, now the laboratory and clinical research profiles are as follows.